{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:09:07Z","timestamp":1791410947471,"version":"4.3.3"},"reference-count":35,"publisher":"Society of Nuclear Medicine","issue":"Supplement 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.2967\/jnumed.120.246066","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T17:20:14Z","timestamp":1625592014000},"page":"26S-33S","source":"Crossref","is-referenced-by-count":20,"title":["A Clinical Challenge: Endocrine and Imaging Investigations of Adrenal Masses"],"prefix":"10.2967","volume":"62","author":[{"given":"Anders","family":"Sundin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Hindi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca M.","family":"Avram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Tabarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ta\u00efeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"key":"2021070610200545000_62.Supplement_2.26S.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp065470"},{"key":"2021070610200545000_62.Supplement_2.26S.2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0461"},{"key":"2021070610200545000_62.Supplement_2.26S.3"},{"key":"2021070610200545000_62.Supplement_2.26S.4","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.165.1.7785642"},{"key":"2021070610200545000_62.Supplement_2.26S.5","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.clinimag.2016.02.006","article-title":"Chemical-shift MRI versus washout CT for characterizing adrenal incidentalomas","volume":"40","author":"Warda","year":"2016","journal-title":"Clin Imaging."},{"key":"2021070610200545000_62.Supplement_2.26S.6","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00261-019-02082-4","article-title":"Mimics, pitfalls, and misdiagnoses of adrenal masses on CT and MRI","volume":"45","author":"Elsayes","year":"2020","journal-title":"Abdom Radiol (NY)."},{"key":"2021070610200545000_62.Supplement_2.26S.7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.7150\/thno.3613","article-title":"Imaging of adrenal masses with emphasis on adrenocortical tumors","volume":"2","author":"Sundin","year":"2012","journal-title":"Theranostics."},{"key":"2021070610200545000_62.Supplement_2.26S.8","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jacr.2017.05.001","article-title":"Management of incidental adrenal masses: a white paper of the ACR Incidental Findings Committee","volume":"14","author":"Mayo-Smith","year":"2017","journal-title":"J Am Coll Radiol."},{"key":"2021070610200545000_62.Supplement_2.26S.9","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0467"},{"key":"2021070610200545000_62.Supplement_2.26S.10","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-1056"},{"key":"2021070610200545000_62.Supplement_2.26S.11","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00330-017-5076-5","article-title":"Pheochromocytoma as a frequent false-positive in adrenal washout CT: A systematic review and meta-analysis","volume":"28","author":"Woo","year":"2018","journal-title":"Eur Radiol."},{"key":"2021070610200545000_62.Supplement_2.26S.12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/0284186X.2011.608084","article-title":"Adrenal lesions in patients with extra-adrenal malignancy: benign or malignant?","volume":"51","author":"Hammarstedt","year":"2012","journal-title":"Acta Oncol."},{"key":"2021070610200545000_62.Supplement_2.26S.13","doi-asserted-by":"crossref","first-page":"101386","DOI":"10.1016\/j.beem.2020.101386","article-title":"Adrenocortical hyperplasia: A multifaceted disease","volume":"34","author":"Bourdeau","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"2021070610200545000_62.Supplement_2.26S.14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00259-002-1025-9","article-title":"11C-metomidate PET imaging of adrenocortical cancer","volume":"30","author":"Khan","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021070610200545000_62.Supplement_2.26S.15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2174"},{"key":"2021070610200545000_62.Supplement_2.26S.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215245"},{"key":"2021070610200545000_62.Supplement_2.26S.17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061"},{"key":"2021070610200545000_62.Supplement_2.26S.18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2021070610200545000_62.Supplement_2.26S.19","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1055\/s-0043-120524","article-title":"The SPARTACUS Trial: controversies and unresolved issues","volume":"49","author":"Beuschlein","year":"2017","journal-title":"Horm Metab Res."},{"key":"2021070610200545000_62.Supplement_2.26S.20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/er.2013-1030","article-title":"Endocrine scintigraphy with hybrid SPECT\/CT","volume":"35","author":"Wong","year":"2014","journal-title":"Endocr Rev."},{"key":"2021070610200545000_62.Supplement_2.26S.21","first-page":"275","article-title":"PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate","volume":"41","author":"Bergstr\u00f6m","year":"2000","journal-title":"J Nucl Med."},{"key":"2021070610200545000_62.Supplement_2.26S.22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1537"},{"key":"2021070610200545000_62.Supplement_2.26S.23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3045"},{"key":"2021070610200545000_62.Supplement_2.26S.24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","article-title":"Targeting CXCR4 (CXC chemokine receptor type 4) for molecular imaging of aldosterone-producing adenoma","volume":"71","author":"Heinze","year":"2018","journal-title":"Hypertension."},{"key":"2021070610200545000_62.Supplement_2.26S.25","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1007\/s00259-020-04722-0","article-title":"Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism","volume":"47","author":"Ding","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021070610200545000_62.Supplement_2.26S.26","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1210\/jc.2017-02324","article-title":"18F-FDOPA PET\/CT Imaging of MAX-related pheochromocytoma","volume":"103","author":"Ta\u00efeb","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"2021070610200545000_62.Supplement_2.26S.27","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","article-title":"European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"46","author":"Ta\u00efeb","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021070610200545000_62.Supplement_2.26S.28","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1177\/0284185118764206","article-title":"68Ga-somatostatin receptor analogs and 18F-FDG PET\/CT in the localization of metastatic pheochromocytomas and paragangliomas with germline mutations: a meta-analysis","volume":"59","author":"Kan","year":"2018","journal-title":"Acta Radiol."},{"key":"2021070610200545000_62.Supplement_2.26S.29","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.211706"},{"key":"2021070610200545000_62.Supplement_2.26S.30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3342"},{"key":"2021070610200545000_62.Supplement_2.26S.31","doi-asserted-by":"crossref","unstructured":"Vyakaranam AR Crona J Norlen O Hellman P Sundin A. 11C-hydroxy-ephedrine-PET\/CT in the diagnosis of pheochromocytoma and paraganglioma. Cancers (Basel). 2019;11.","DOI":"10.3390\/cancers11060847"},{"key":"2021070610200545000_62.Supplement_2.26S.32","doi-asserted-by":"crossref","first-page":"20170520","DOI":"10.1259\/bjr.20170520","article-title":"Diagnostic accuracy of 18F-FDG PET or PET\/CT for the characterization of adrenal masses: a systematic review and meta-analysis","volume":"91","author":"Kim","year":"2018","journal-title":"Br J Radiol."},{"key":"2021070610200545000_62.Supplement_2.26S.33","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1210\/jc.2017-00254","article-title":"Performance of 18F-FDG PET\/CT in the characterization of adrenal masses in noncancer patients: a prospective study","volume":"102","author":"Guerin","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"2021070610200545000_62.Supplement_2.26S.34","doi-asserted-by":"crossref","unstructured":"Abdul Sater Z Jha A Hamimi A . Pheochromocytoma and paraganglioma patients with poor survival often show brown adipose tissue activation. J Clin Endocrinol Metab. 2020;105:1176\u20131185.","DOI":"10.1210\/clinem\/dgz314"},{"key":"2021070610200545000_62.Supplement_2.26S.35","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.11100569"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.120.246066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T17:22:45Z","timestamp":1625592165000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.120.246066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":35,"journal-issue":{"issue":"Supplement 2","published-online":{"date-parts":[[2021,7,6]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.2967\/jnumed.120.246066"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.120.246066","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}